Source: Annual Congress 2010 - Quality management for lung cancer patients
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
U. Oltmanns, B. Yung, S. Cooper, D. Powrie (Cambridge, Basildon, Colchester, Southend-on-Sea, United Kingdom). A network lung cancer pathway in review: Are we choosing the right diagnostic approach?. Eur Respir J 2010; 36: Suppl. 54, 303

Member's Comments

No comment yet.

Related content which might interest you: Panel discussion: Improving the pathway of lung cancer patients, can we do it better? Source: ERS webinar 2021: Panel discussion on improving the pathway of lung cancer patients, can we do it better? Year: 2021 Modern staging in lung cancer: from the current multidisciplinary process to novel approaches Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Evolution in the diagnostic approach to lung cancer Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Patient perspectives and experience on the diagnostic pathway of lung cancer – a qualitative study Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care Year: 2018 An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006 Nurse led lung cancer diagnostic/supportive follow up clinic;a different approach to optimise lung cancer pathway Source: International Congress 2018 – The many facets of respiratory nursing Year: 2018 Development of a pulmonary nodule service & clinical pathway: A pragmatic approach addressing an unmet need Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016 A new classification system for NSCLC: what do we expect from imaging? Source: Annual Congress 2009 - The new classification system of nonsmall cell lung cancer: a challenge for imaging Year: 2009 ALK- and ROS-1-inhibition: a relevant treatment strategy for lung cancer? Source: International Congress 2014 – Update on lung cancer biology for clinicians Year: 2014 Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Surgery for non small cell lung cancer (NSCLC) and functional limits: is there a possible beneficial role of preoperative pulmonary rehabilitation? Source: Eur Respir J 2004; 24: Suppl. 48, 522s Year: 2004 Eminence or evidence based ? – personalised diagnostic-therapeutic sequences in a molecular altered advanced NSCLC patient Source: International Congress 2017 – GR2 Lung Cancer Grand Round Year: 2017 EU-USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer Source: Eur Respir J 2006; 28: 1186-1189 Year: 2006 The 5000% case: a glimpse into the financial issue of lung cancer treatment Source: Eur Respir J 2016; 47:1331-1333 Year: 2016 A new diagnostic procedure for determining invasion to mediastineum in patients with lung cancer: cardiac vagal activity measurement Source: Eur Respir J 2003; 22: Suppl. 45, 252s Year: 2003 Pulmonologists and lung cancer: pivotal role in multidisciplinary approach Source: Eur Respir J 2013; 42: 1183-1185 Year: 2013 Is our approach to basic research right? Pitfalls and successes: what is the way forward? Source: ERS Research Seminar 2016 Year: 2016 Is CT-based screening for lung cancer finally ready for prime time? Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer Year: 2012